News
The company, which produces novel therapies to treat highly progressive retinal diseases, said it has laid off 80% of its total workforce. Chief Executive Fred Guerard and Finance Chief Tom Reilly ...
Just a bump in the road? The post Expert sees strong upside for this ASX 200 mining stock after major production setback ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback